Advanced Wound Healing and Scar Reduction Using an Innovative Anti-ROS Polysaccharide Hydrogel with Recombinant Human Collagen Type III
ACS Applied Materials & Interfaces · 2024
DOI: 10.1021/acsami.4c09890 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2024. Verfasst von Xinyue Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: National Engineering Research Center for Biomaterials, Sichuan University, 29# Wangjiang Road, Chengdu, Sichuan 610064, China. Hauptthemen laut MEDLINE: Wound Healing, Collagen Type III, Hydrogels, Cicatrix. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 58 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Science and Technology Department of Sichuan Province, Fundamental Research Funds for the Central Universities.
Themen: Wundversorgung
Abstract (Originalsprache)
Excessive fibrotic scar formation during skin defect repair poses a formidable challenge, impeding the simultaneous acceleration of wound healing and prevention of scar formation and hindering the restoration of skin integrity and functionality. Drawing inspiration from the structural, compositional, and biological attributes of skin, we developed a hydrogel containing modified recombinant human collagen type III and thiolated hyaluronic acid to address the challenges of regenerating skin appendages and improving the recovery of skin functions after injury by reducing fibrotic scarring. The hydrogel displayed favorable biocompatibility, antioxidant properties, angiogenic potential, and fibroblast migration stimulation in vitro. In a rat full-layer defect model, it reduced inflammation, promoted microvascular formation, and significantly enhanced the wound healing speed and effectiveness. Additionally, by upregulating fibrosis-associated genes, such as TGFB1, it facilitated collagen accumulation and a beneficial balance between type I and type III collagen, potentially expediting skin regeneration and functional recovery. In conclusion, the utilization of rhCol III-HS demonstrated considerable potential as a wound dressing, offering a highly effective strategy for the restoration and rejuvenation of complete skin defects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Engineering Research Center for Biomaterials, Sichuan University, 29# Wangjiang Road, Chengdu, Sichuan 610064, China.
- College of Biomedical Engineering, Sichuan University, 29# Wangjiang Road, Chengdu, Sichuan 610064, China.
- Jiangsu Trautec Medical Technology Co., Ltd, 18# Jincheng Road, Changzhou, Jiangsu 213251, China.
- Sichuan Testing Center for Biomaterials and Medical Devices, Chengdu 610064, China.
ORCID-Profile: Yawen Huang, Yafang Chen, Yujiang Fan
Förderung
- National Key Research and Development Program of China
- Science and Technology Department of Sichuan Province
- Fundamental Research Funds for the Central Universities
- National Natural Science Foundation of China
Zitieren
APA
Zhang, X., Huang, Y., Luo, T., Hu, C., Li, H., Fan, X., Wang, K., Liang, J., Chen, Y., & Fan, Y. (2024). Advanced Wound Healing and Scar Reduction Using an Innovative Anti-ROS Polysaccharide Hydrogel with Recombinant Human Collagen Type III. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.4c09890
Vancouver
Zhang X, Huang Y, Luo T, Hu C, Li H, Fan X, et al. Advanced Wound Healing and Scar Reduction Using an Innovative Anti-ROS Polysaccharide Hydrogel with Recombinant Human Collagen Type III. ACS Applied Materials & Interfaces. 2024. doi:10.1021/acsami.4c09890
BibTeX
@article{Zhang2024,
author = {Zhang, Xinyue and Huang, Yawen and Luo, Tao and Hu, Chen and Li, Haihang and Fan, Xiaoju and Wang, Kefeng and Liang, Jie and Chen, Yafang and Fan, Yujiang},
title = {Advanced Wound Healing and Scar Reduction Using an Innovative Anti-ROS Polysaccharide Hydrogel with Recombinant Human Collagen Type III},
journal = {ACS Applied Materials & Interfaces},
year = {2024},
doi = {10.1021/acsami.4c09890}
}
EUVIMED